ProMIS Neurosciences, Inc. (PMN)
9.67
+0.52
(+5.68%)
USD |
NASDAQ |
Oct 09, 13:14
ProMIS Neurosciences Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | -59.30K% |
| December 31, 2021 | -25.79K% |
| September 30, 2021 | -19.08K% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -263.3K% |
| September 30, 2020 | |
| June 30, 2020 | -108.3K% |
| March 31, 2020 | |
| December 31, 2019 | -122.3K% |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | -659.4K% |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | -442.8K% |
| September 30, 2017 | -17.94K% |
| June 30, 2017 | |
| March 31, 2017 | -207.4K% |
| December 31, 2016 | -453.8K% |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | -27.10K% |
| Date | Value |
|---|---|
| December 31, 2015 | |
| September 30, 2015 | -9.24K% |
| June 30, 2015 | -32.49K% |
| March 31, 2015 | -3.75K% |
| December 31, 2014 | -818.7% |
| September 30, 2014 | -1.20K% |
| June 30, 2014 | -677.2% |
| March 31, 2014 | -830.7% |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | -1.76K% |
| December 31, 2012 | -3.24K% |
| September 30, 2012 | -71.92K% |
| June 30, 2012 | -37.10K% |
| March 31, 2012 | |
| December 31, 2011 | -3.95K% |
| September 30, 2011 | -1.47K% |
| June 30, 2011 | -1.61K% |
| March 31, 2011 | -3.21K% |
| December 31, 2010 | -8.08K% |
| September 30, 2010 | 7.61% |
| June 30, 2010 | -7.05K% |
| March 31, 2010 | -200.2K% |
| December 31, 2009 | -2.56K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Edesa Biotech, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
| Sarepta Therapeutics, Inc. | -1.22% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -179.4% |
| Return on Assets | -128.5% |
| Return on Invested Capital | -179.4% |
| Return on Net Operating Assets | -24.04K% |